OTC Markets OTCPK - Delayed Quote USD

Nowtransit Inc. (NOTR)

1.0000 -10.0000 (-90.91%)
At close: February 3 at 3:53 PM EST
Loading Chart for NOTR
DELL
  • Previous Close 11.0000
  • Open 13.0000
  • Bid --
  • Ask --
  • Day's Range 1.0000 - 1.0000
  • 52 Week Range 1.0000 - 13.0000
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 41.596M
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nowtransit Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide; and Metabolism+ to enhance metabolism. It sells its products through Amazon platform; wholesales through online platform; private label sales; and direct sales. The company is based in Salt Lake City, Utah.

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NOTR

Performance Overview: NOTR

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NOTR
92.31%
S&P 500
10.64%

1-Year Return

NOTR
92.31%
S&P 500
25.49%

3-Year Return

NOTR
81.82%
S&P 500
25.00%

5-Year Return

NOTR
81.82%
S&P 500
25.00%

Compare To: NOTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NOTR

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -27.78%

  • Return on Assets (ttm)

    -160.67%

  • Return on Equity (ttm)

    -1,810.46%

  • Revenue (ttm)

    842.86k

  • Net Income Avi to Common (ttm)

    -234.16k

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92.94k

  • Total Debt/Equity (mrq)

    29.44%

  • Levered Free Cash Flow (ttm)

    -199.41k

Research Analysis: NOTR

Company Insights: NOTR

Research Reports: NOTR